entertainment -WSS

entertainment

author：explore 2025-10-02 18:48:53 - browse：948

Chief executive officer of Sanofi Paul Hudson, wearing glasses, speaks into a mic — pharma coverage from STAT — Sanofi CEO Paul Hudson Carolyn Kaster/AP

LONDON — Sanofi CEO Paul Hudson on Wednesday defended his company’s recent moves to abandon future profit guidance and up its investment in its own research programs, arguing that the dramatically negative market response didn’t reflect the potential rewards that could stem from the plan.

“Would I have liked the stock market reaction to be more generous? Of course,” Hudson said at a Financial Times event in London. “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division. As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. Company executives have argued that this was the moment — when Sanofi has a strong pipeline and isn’t facing patent expirations for years — to increase its R&D resources, even at the expense of short-term profits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

focus

WSS

Achieving telehealth equity for people with hearing loss

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Timeline: Special counsel's probe into Trump's handling of classified documents

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Asahi Kasei to buy Calliditas, picking up kidney disease drug

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

entertainment

entertainment

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

J&J reports mixed data on next

Duchenne breakthrough therapy leaves behind pioneering families

Marc Tessier

After affirmative action ruling, medical educators look to 'holistic review'

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

In age of alternative facts, a scholarly course on calling out crap

Ford recalls 870K F

Bright Health sells Medicare Advantage business to Molina

Biden jokes that Republicans may impeach him because inflation is starting to cool down

focus

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Will biotech layoffs continue through 2023?

Why some fertility treatments produce more boy babies

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Unmasking the 'centricity' illusion in clinical trials

Pharma’s losing bet in New Jersey

focus

hotspot

focus

explore